Skip to main content
bioRxiv
  • Home
  • Submit
  • FAQ
  • Blog
  • ALERTS / RSS
  • About
  • Channels
    Advanced Search
    bioRxiv posts many COVID19-related papers. A reminder: they have not been formally peer-reviewed and should not guide health-related behavior or be reported in the press as conclusive.
    New Results Follow this preprint

    Inpatient mobility to predict hospital-onset Clostridium difficile: a network approach

    Kristen Bush, Hugo Barbosa, Samir Farooq, Samuel J. Weisenthal, Melissa Trayhan, Robert J. White, Gourab Ghoshal, View ORCID ProfileMartin S. Zand
    doi: https://doi.org/10.1101/404160
    This article is a preprint and has not been certified by peer review [what does this mean?].
    00000030 Comments0 TRiP Peer Reviews0 Community Reviews0 Automated Evaluations0 Blog/Media Links0 Videos3 Tweets
    • Abstract
    • Full Text
    • Info/History
    • Metrics
    • Supplementary material
    • Preview PDF

    Abstract

    With hospital-onset Clostridium difficile Infection (CDI) still a common occurrence in the U.S., this paper examines the relationship between unit-wide CDI susceptibility and inpatient mobility and creates a predictive measure of CDI called “Contagion Centrality”. A mobility network was constructed using two years of patient electronic health record (EHR) data within a 739-bed hospital (Jan. 2013 - Dec. 2014; n=72,636 admissions). Network centrality measures were calculated for each hospital unit (node) providing clinical context for each in terms of patient transfers between units (edges). Daily unit-wide CDI susceptibility scores were calculated using logistic regression and compared to network centrality measures to determine the relationship between unit CDI susceptibility and patient mobility. Closeness centrality was a statistically significant measure associated with unit susceptibility (p-value < 0.05), highlighting the importance of incoming patient mobility in CDI prevention at the unit-level. Contagion Centrality (CC) was calculated using incoming inpatient transfer rates, unit-wide susceptibility of CDI, and current hospital CDI infections. This measure is statistically significant (p-value <0.05) with our outcome of hospital-onset CDI cases, and captures the additional opportunities for transmission associated with inpatient transfers. We have used this analysis to create an easily interpretable and informative clinical tool showing this relationship and risk of hospital-onset CDI in real-time. Quantifying and visualizing the combination of inpatient transfers, unit-wide risk, and current infections help identify hospital units at risk of developing a CDI outbreak, and thus provide clinicians and infection prevention staff with advanced warning and specific location data to concentrate prevention efforts.

    Copyright 
    The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
    Back to top
    PreviousNext
    Posted September 20, 2018.
    Download PDF
    Print/Save Options

    Supplementary Material

    Email
    Share
    Citation Tools
    • Tweet Widget
    COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

    Subject Area

    • Epidemiology
    Subject Areas
    All Articles
    • Animal Behavior and Cognition (3817)
    • Biochemistry (8107)
    • Bioengineering (5900)
    • Bioinformatics (21853)
    • Biophysics (10933)
    • Cancer Biology (8492)
    • Cell Biology (12325)
    • Clinical Trials* (138)
    • Developmental Biology (6992)
    • Ecology (10693)
    • Epidemiology* (2065)
    • Evolutionary Biology (14271)
    • Genetics (9905)
    • Genomics (13321)
    • Immunology (8448)
    • Microbiology (20661)
    • Molecular Biology (8147)
    • Neuroscience (44285)
    • Paleontology (329)
    • Pathology (1324)
    • Pharmacology and Toxicology (2329)
    • Physiology (3476)
    • Plant Biology (7452)
    • Scientific Communication and Education (1349)
    • Synthetic Biology (2068)
    • Systems Biology (5670)
    • Zoology (1161)
    * The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).

    Evaluation/discussion of this paper   x